Gordon & Rees will host the Food and Drug Law Institute’s Course, “Introduction to Law and Regulation – Drug and Medical Device,” in our San Francisco office on November 9-10.
This unique combination course will give participants a comprehensive overview of the laws and Food and Drug Administration (FDA) regulations affecting both the drug and medical devices industries. All attendees will benefit from expert speakers on topics including bringing new products to market, key principals in advertising and promotion, and enforcement considerations.
Breakout sessions for individuals interested in either the Drug or Medical Device track will benefit from industry specific topics, including Biologics and Biosimilars, Clinical Investigations and the New Drug Approval Process. Participants on both tracks will better understand key FDA regulations and policies as experts help you determine how those regulations and policies are applied. Attendees will have multiple opportunities to ask questions of the speakers, including those on developing issues affecting both the drug and device industries.
This interactive, two-day course will be of interest for new professionals in the drug and medical device industries as well as seasoned regulatory affairs or legal professionals looking for a refresher on current FDA policies and practices.
Gordon & Rees partners, Kai Peters, Reg Reilly, and Andrew Cary will present “Regulation of Drug and Medical Device Marketing – Key Principles of Advertising and Promotion.” The presentation will review the scope of FDA authority of drug and medical device advertising and promotion, define “label” and “labeling” and “false and misleading,” and cover off-label and other current issues.
For registration and full agenda, please visit: http://www.fdli.org/westcoastcombinedcourse/.